DE69521012T2 - Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten - Google Patents

Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten

Info

Publication number
DE69521012T2
DE69521012T2 DE69521012T DE69521012T DE69521012T2 DE 69521012 T2 DE69521012 T2 DE 69521012T2 DE 69521012 T DE69521012 T DE 69521012T DE 69521012 T DE69521012 T DE 69521012T DE 69521012 T2 DE69521012 T2 DE 69521012T2
Authority
DE
Germany
Prior art keywords
azetidinethiol
thiazolyl
dihydro
derivatives
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69521012T
Other languages
English (en)
Other versions
DE69521012D1 (de
Inventor
Kazuhiko Hayashi
Chisato Sato
Satoshi Tamai
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Japan Inc
Original Assignee
Wyeth Lederle Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Lederle Japan Ltd filed Critical Wyeth Lederle Japan Ltd
Application granted granted Critical
Publication of DE69521012D1 publication Critical patent/DE69521012D1/de
Publication of DE69521012T2 publication Critical patent/DE69521012T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Processing Of Solid Wastes (AREA)
  • Saccharide Compounds (AREA)
  • Chemical Vapour Deposition (AREA)
DE69521012T 1994-12-12 1995-12-11 Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten Expired - Lifetime DE69521012T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP33142394 1994-12-12
JP25728195 1995-09-11

Publications (2)

Publication Number Publication Date
DE69521012D1 DE69521012D1 (de) 2001-06-28
DE69521012T2 true DE69521012T2 (de) 2001-09-06

Family

ID=26543132

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69521012T Expired - Lifetime DE69521012T2 (de) 1994-12-12 1995-12-11 Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten

Country Status (15)

Country Link
US (1) US5659043A (de)
EP (1) EP0717042B1 (de)
KR (1) KR100337053B1 (de)
AT (1) ATE201410T1 (de)
AU (1) AU703119B2 (de)
CA (1) CA2164918C (de)
DE (1) DE69521012T2 (de)
DK (1) DK0717042T3 (de)
ES (1) ES2156917T3 (de)
FI (1) FI120402B (de)
GR (1) GR3035925T3 (de)
HU (4) HU223472B1 (de)
IL (1) IL116331A (de)
NO (1) NO955007L (de)
PT (1) PT717042E (de)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
KR100621782B1 (ko) * 2004-06-14 2006-09-19 한국과학기술연구원 1-베타메틸카바페넴 유도체 및 이의 제조방법
CN102532139A (zh) * 2010-12-07 2012-07-04 重庆医药工业研究院有限责任公司 一种替比培南的制备方法
CN102731502B (zh) * 2011-04-13 2016-08-03 石药集团中奇制药技术(石家庄)有限公司 一种碳青霉烯抗生素的制备方法
CN102731503B (zh) * 2011-04-13 2016-02-03 石药集团中奇制药技术(石家庄)有限公司 一种泰比培南的制备方法
CN102250080B (zh) * 2011-04-26 2015-06-03 广州白云山制药股份有限公司广州白云山制药总厂 一种1-(4,5-二氢-2-噻唑啉基)-3-巯基吖丁叮盐酸盐的制备方法
CN102757430B (zh) * 2011-04-29 2016-04-13 上海医药工业研究院 一种替比培南的制备方法
CN104292222B (zh) * 2013-07-17 2017-05-10 常州锐博生物科技有限公司 一种替比培南匹伏酯侧链的新的合成方法
AU2016288230A1 (en) 2015-07-02 2018-01-25 Horizon Orphan Llc ADO-resistant cysteamine analogs and uses thereof
CN112321582B (zh) * 2020-11-03 2021-12-03 江西富祥药业股份有限公司 一种泰比培南侧链的合成及中间体的精制方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU682510B2 (en) * 1993-07-01 1997-10-09 Pfizer Japan Inc. 2-(1-(1,3-thiazolin-2-yl)azetidin-3-yl)thio-carbapenem derivatives

Also Published As

Publication number Publication date
HUT75098A (en) 1997-04-28
AU4035995A (en) 1996-06-20
EP0717042B1 (de) 2001-05-23
GR3035925T3 (en) 2001-08-31
HU0203890D0 (en) 2003-01-28
US5659043A (en) 1997-08-19
IL116331A0 (en) 1996-03-31
FI955954A0 (fi) 1995-12-12
HU223536B1 (hu) 2004-08-30
HU0203892D0 (en) 2003-01-28
EP0717042A1 (de) 1996-06-19
FI955954A (fi) 1996-06-13
CA2164918A1 (en) 1996-06-13
HU223472B1 (hu) 2004-07-28
KR100337053B1 (ko) 2002-11-07
KR960022512A (ko) 1996-07-18
ES2156917T3 (es) 2001-08-01
HU223477B1 (hu) 2004-07-28
FI120402B (fi) 2009-10-15
AU703119B2 (en) 1999-03-18
CA2164918C (en) 2007-09-25
IL116331A (en) 2000-02-17
HU223476B1 (hu) 2004-07-28
NO955007L (no) 1996-06-13
ATE201410T1 (de) 2001-06-15
HU9503548D0 (en) 1996-02-28
DE69521012D1 (de) 2001-06-28
DK0717042T3 (da) 2001-08-06
HU0203891D0 (en) 2003-01-28
NO955007D0 (no) 1995-12-11
PT717042E (pt) 2001-08-30

Similar Documents

Publication Publication Date Title
DE69534029D1 (de) Herstellung von Camptothecinderivaten durch intramolekulare Cyclisierung
NO306780B1 (no) Carbapenem-antibiotika
DE69327567T2 (de) Verfahren zur Herstellung von Alanylglutamin
DE69521012D1 (de) Verfahren zur Herstellung von 1-(4,5-Dihydro)2-thiazolyl-3-Azetidinthiolderivaten
DE69231815D1 (de) Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
DE69222012T2 (de) Verfahren zur Herstellung von Alpha-Ketoamidderivaten
DE60000402T2 (de) Prozess zur herstellung von zwischebprodukten für imidazodeazepinen
DE69109913T2 (de) Cephalosporinzwischenverbindungen, Verfahren zu ihrer Herstellung sowie zur Herstellung ihrer Endprodukte.
DE60136566D1 (de) Verfahren zur herstellung von optisch aktiven 2,4-dihydrobenzofuranverbindungen
BR8502884A (pt) Derivado de azetidina e processo para preparar acido azetidino-3-carboxilico
DE69331792D1 (de) Verfahren zur Herstellung von 2-Oxopyrrolidinylacetamid-Derivaten
DE69127960T2 (de) Verfahren zur Herstellung von (S)-vinyl- und (S)-allenyl-Gaba
DE69928610D1 (de) Verfahren zur Herstellung von 2-Carbamoyl-Pyridinen
ATE249434T1 (de) Ein verfahren zur herstellung von pyrrolidinon- derivaten
ATE244228T1 (de) Verfahren zur herstellung von chloroacetylaminothiazoleaceticsäure derivate
DE69913736T2 (de) Siastatin derivate mit glycosidase inhinbor-aktivität und ein verfahren zur herstellung derselben

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: WYETH K.K., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: PFIZER JAPAN INC., TOKIO/TOKYO, JP